Companies To Watch

  1. Companies To Watch: Spruce Biosciences 10/2/2023

    Spruce Biosciences is currently in mid-to-late stage clinical development of new agents to treat rare endocrine disorders.

  2. Companies To Watch: Nido Biosciences 9/1/2023

    See why Nido Biosciences is developing small molecule drugs for rare neurodegenerative diseases.

  3. Companies To Watch: Ventoux Biosciences 8/1/2023

    Why Ventoux Biosciences is pursuing drug treatments for all sufferers of Dupuytren’s and other fibroproliferative diseases.

  4. Companies To Watch: Kinaset Therapeutics 7/3/2023

    Kinaset Therapeutics is moving fast in the respiratory space to advance a potential first-time therapy.

  5. Companies To Watch: Orca Bio 6/1/2023

    Orca Bio is creating a new cell therapy aimed at bringing rebirth to stem-cell transplantation.

  6. Companies To Watch: Sonoma Biotherapeutics 5/1/2023

    Sonoma Biotherapeutics is bioengineering T cells to create potential cures for autoimmune and inflammatory conditions.

  7. Companies To Watch: KaliVir Immunotherapeutics 4/3/2023

    KaliVir Immunotherapeutics is engineering oncolytic viruses with novel transgenes, and joining them to other immunotherapies, to defeat cancer and cancer relapse.

  8. Companies To Watch: Hummingbird Bioscience 3/1/2023

    Hummingbird Bioscience is joining the forces of computational and systems biology to fight cancer and autoimmune disease.

  9. Companies To Watch: Corner Therapeutics 2/1/2023

    Corner Therapeutics is focused on discovering new small molecules that could mimic the body’s natural immune response to generate the robust T-cell response.

  10. Companies To Watch: Ocelot Bio 1/3/2023

    Ocelot Bio is focusing a single drug on multiple complications of end-stage liver disease.